Literature DB >> 1289268

Differential diagnosis of adrenal tumour and upper pole renal tumour by I-131 cholesterol adrenocortical scintigraphy.

M Takeda1, T Torii, T Nishiyama, Y Katayama, T Tsutsui, T Komeyama, M Takeda1, M Kimura.   

Abstract

A 27-year-old housewife with right hypochondralgia was admitted for treatment of a huge right adrenal or upper pole renal tumour. The tumour measured 10 x 8 x 8 cm and was hypovascular. The main blood supply derived from the right adrenal artery which originated from the abdominal aorta just proximal to the right renal artery. Although several diagnostic imaging studies suggested that the tumour arose from the right adrenal gland, the bilateral adrenal glands were equally visualized on I-131 cholesterol adrenocortical scintigraphy. After surgery and pathological examination, the tumour proved to be a renal cell cancer, while the right adrenal gland was intact. This case demonstrates that adrenocortical scintigraphy is useful in the differentiation of adrenal and renal tumours when a large tumour occupies the upper pole of the kidney or adrenal gland.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289268     DOI: 10.1007/bf02551293

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  3 in total

1.  Vascular specificity in differentiating adrenal carcinoma from renal cell carcinoma.

Authors:  P Fritzsche; C Andersen; P Cahill
Journal:  Radiology       Date:  1977-10       Impact factor: 11.105

Review 2.  Imaging strategies for tumors of the kidney, adrenal gland, and retroperitoneum.

Authors:  A J Davidson; D S Hartman
Journal:  CA Cancer J Clin       Date:  1987 May-Jun       Impact factor: 508.702

3.  Adrenal tumors simulating intrarenal lesions.

Authors:  G G Shrago; C M McKinnon; R Clark
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-07
  3 in total
  1 in total

1.  Renal cell carcinoma mimicking adrenal tumor.

Authors:  Mohammad Kazem Moslemi; Shabir Al-Mousawi; Mohammad Hasan Dehghani Firoozabadi
Journal:  J Oncol       Date:  2010-08-23       Impact factor: 4.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.